← Eichor
Condition: Hereditary Neoplastic Syndrome Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hereditary Neoplastic Syndrome

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Li-Fraumeni Syndrome/TP53 Biobank
Phase N/A · 2 location(s) · Abramson Cancer Center at Penn Medicine · NCT04367246Topotecan and Melphalan for Retinoblastoma
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT04799002AnovaOS Network Powered Patient Registry
Phase N/A · 1 location(s) · Anova Enterprises, Inc · NCT05013944Mirdametinib in Patients With Advanced NF1-mutant Melanoma
Phase 2 · 1 location(s) · Kevin Kim, MD · NCT07237100A Personalized Surveillance and Intervention Protocol for Patients With Familial Adenomatous Polyposis That Have Undergo
Phase N/A · 2 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT04678011PSYLIVED: the Psychological Impacts of Living With an Inherited Colorectal Cancer Predisposition Syndrome
Phase N/A · 1 location(s) · London North West Healthcare NHS Trust · NCT06447961Uncovering Genes Behind Cartilage Tumors and Vascular Anomalies Using Genomic Sequencing
Phase N/A · 1 location(s) · Eunice Kennedy Shriver National Institute of Child Health an · NCT06749366Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Phase 2 · 18 location(s) · VA Office of Research and Development · NCT04038502Clinical Application of Al18F-NOTA-FAPI-04 PET/CT or PET/MRI Imaging in Malignant Tumor,Cardiovascular or Immune Disease
Phase 1/Phase 2 · 1 location(s) · Peking Union Medical College Hospital · NCT07400224Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
Phase 1 · 5 location(s) · National Cancer Institute (NCI) · NCT05630794Motiva Flora® Aesthetic Breast Recon® Clinical Study
NA · 4 location(s) · Establishment Labs · NCT06146231Menstrual Cup for Early Endometrial Cancer Detection in Lynch Syndrome
NA · 1 location(s) · Jessica D. St. Laurent, MD · NCT07220239Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute M
Phase 1 · 22 location(s) · National Cancer Institute (NCI) · NCT06484062Multi-modal Quantitative Imaging of the Skin
Phase N/A · 3 location(s) · HJN Sverige AB/Neko Health · NCT06989216Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism?
EARLY_Phase 1 · 1 location(s) · University of Virginia · NCT04723862Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biologica
Phase N/A · 5 location(s) · National Cancer Institute (NCI) · NCT01109394Prospective Multicenter Registry Study to Assess the Frequency of Lynch Syndrome Among Patients With Colorectal Cancer
Phase N/A · 1 location(s) · State Scientific Centre of Coloproctology, Russian Federatio · NCT05495776Ovarian Tissue Cryopreservation in Pre-Pubertal (OTC-Pre Pubertal)
Phase N/A · 1 location(s) · Erin Rowell · NCT05299710Prospective Observational Study on SEBBIN Silicone Gel-filled Testicular Implants
Phase N/A · 1 location(s) · University Hospital, Ghent · NCT05097820Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT07019155The Prospective Observational COMPRAYA Cohort Study
Phase N/A · 1 location(s) · The Netherlands Cancer Institute · NCT04682470Willingness to Participate in a Trial Comparing Standard Genetic Counseling Versus Personalized Genetic Counseling
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT05126810A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Bl
Phase 1 · 21 location(s) · AstraZeneca · NCT07064122Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations
Phase N/A · 1 location(s) · Institute of Cancer Research, United Kingdom · NCT02705846AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
Phase 2 · 1 location(s) · Mitchell Cairo · NCT04099966Early Detection of Endometrial/Ovarian Cancer and Hereditary Predisposition of These Cancers
NA · 2 location(s) · McGill University · NCT04891029A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ov
Phase N/A · 1 location(s) · Peking University Third Hospital · NCT07532434Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma
Phase N/A · 2 location(s) · National Cancer Institute (NCI) · NCT00040352Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours
Phase 1 · 13 location(s) · DeuterOncology · NCT05752552A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syn
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT05411718
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.